Can These Two Pot Stocks Continue to Show Growth Despite Covid-19? It…

The post Are These Two Marijuana Stocks Long Term Options? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
A Department of Justice office tasked with investigating claims of misconduct in the agency has determined that antitrust prosecutors did not violate rules when they looked into cannabis industry mergers at the request of Attorney General William Barr. Last week, two whistleblowers at the DOJ’s antitrust division (ATR) testified... Read more
Marijuana often demonstrates the ability to win over even the most conservative of individuals. That said, winning over the hearts and minds of America’s vast regions isn’t complete until cannabis endears itself to the nation’s most conservative citizens and lawmakers in the southeast.  Recent activity indicates that it may... Read more

 Will Next Month Produce Gains For These Marijuana Stocks The month of…

The post Two Marijuana Stocks To Watch Heading Into July  appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
Even though Virginia has decriminalized cannabis as of first thing next month, the state’s Black caucus would like to see things move to full legalization. Their plan is to try and push that through in a special legislative session this summer.  “The Commonwealth is past the point for studies... Read more
Seven out of ten Americans believe that smoking marijuana is morally acceptable, according to a poll that tracks values and beliefs in the United States. Results of the poll that surveys American’s views on the moral acceptability of 21 different social issues were released this week by Gallup. When... Read more
Regulators in the United Kingdom have rescheduled the cannabidiol drug Epidyolex as a Schedule 5 drug, moving the medicine approved to treat severe forms of epilepsy from the much more restrictive Schedule 2 classification. GW Pharmaceuticals, the manufacturer of the medication, announced on Tuesday that the move by the... Read more
Dr. Lester Grinspoon, one of the most vocal champions of marijuana legalization in the United States who promoted his advocacy in both best-selling books and Congressional testimony, died on Thursday. He was 92.  A native of Massachusetts, Grinspoon studied at Harvard Medical School, and later joined the faculty there... Read more

Can These Pot Stocks Show Value In The Coming Months? When we…

The post Are These Marijuana Stocks Worth The Investment? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )